Literature DB >> 16565501

Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.

Roy W R Dudley1, Gawiyou Danialou, Karuthapillai Govindaraju, Larry Lands, David E Eidelman, Basil J Petrof.   

Abstract

Dystrophin deficiency is the cause of Duchenne muscular dystrophy, but the precise physiological basis for muscle necrosis remains unclear. To determine whether dystrophin-deficient muscles are abnormally susceptible to oxidative and nitric oxide (NO)-driven tissue stress, a hindlimb ischemia/reperfusion (I/R) model was used. Dystrophic mdx mice exhibited abnormally high levels of lipid peroxidation and protein nitration, which were preceded by exaggerated NO production during ischemia. Visualization of NO with the fluorescent probe 4,5-diaminofluorescein diacetate suggested that excess NO production during ischemia occurred within a subset of mdx fibers. In mdx muscles only, prior exposure to I/R dramatically increased the level of sarcolemmal damage resulting from stretch-mediated mechanical stress, indicating greatly exacerbated hyperfragility of the dystrophic fiber membrane. Treatment with NO synthase inhibitors (l-N(G)-nitroarginine methyl ester hydrochloride or 7-nitroindazol) effectively blocked the synergistic interaction between I/R and mechanical stress-mediated sarcolemmal damage under these conditions. Taken together, our findings provide direct ex-perimental evidence that several prevailing hy-potheses regarding the cause of muscle fiber damage in dystrophin-deficient muscle can be integrated into a common pathophysiological framework involving interactions between oxidative stress, ab-normal NO regulation, and hyperfragility of the sarcolemma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565501      PMCID: PMC1606574          DOI: 10.2353/ajpath.2006.050683

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  72 in total

1.  Dystrobrevin and dystrophin: an interaction through coiled-coil motifs.

Authors:  H M Sadoulet-Puccio; M Rajala; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

2.  Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice.

Authors:  V Brussee; F Tardif; J P Tremblay
Journal:  Neuromuscul Disord       Date:  1997-12       Impact factor: 4.296

3.  Muscle cells from mdx mice have an increased susceptibility to oxidative stress.

Authors:  T A Rando; M H Disatnik; Y Yu; A Franco
Journal:  Neuromuscul Disord       Date:  1998-02       Impact factor: 4.296

4.  Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise.

Authors:  J T Vilquin; V Brussee; I Asselin; I Kinoshita; M Gingras; J P Tremblay
Journal:  Muscle Nerve       Date:  1998-05       Impact factor: 3.217

Review 5.  Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance.

Authors:  M B Reid
Journal:  Acta Physiol Scand       Date:  1998-03

6.  Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore.

Authors:  H Kojima; K Sakurai; K Kikuchi; S Kawahara; Y Kirino; H Nagoshi; Y Hirata; T Nagano
Journal:  Chem Pharm Bull (Tokyo)       Date:  1998-02       Impact factor: 1.645

7.  mdx muscle pathology is independent of nNOS perturbation.

Authors:  R H Crosbie; V Straub; H Y Yun; J C Lee; J A Rafael; J S Chamberlain; V L Dawson; T M Dawson; K P Campbell
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

8.  Functional nitric oxide synthase mislocalization in cardiomyopathy.

Authors:  Ahlke Heydemann; Jill M Huber; Rahul Kakkar; Matthew T Wheeler; Elizabeth M McNally
Journal:  J Mol Cell Cardiol       Date:  2004-02       Impact factor: 5.000

9.  Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers.

Authors:  Ashok Kumar; Niraj Khandelwal; Rahul Malya; Michael B Reid; Aladin M Boriek
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

10.  Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.

Authors:  V Straub; J A Rafael; J S Chamberlain; K P Campbell
Journal:  J Cell Biol       Date:  1997-10-20       Impact factor: 10.539

View more
  30 in total

1.  S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction.

Authors:  Costanza Montagna; Giuseppina Di Giacomo; Salvatore Rizza; Simone Cardaci; Elisabetta Ferraro; Paolo Grumati; Daniela De Zio; Emiliano Maiani; Carolina Muscoli; Filomena Lauro; Sara Ilari; Sergio Bernardini; Stefano Cannata; Cesare Gargioli; Maria R Ciriolo; Francesco Cecconi; Paolo Bonaldo; Giuseppe Filomeni
Journal:  Antioxid Redox Signal       Date:  2014-05-13       Impact factor: 8.401

2.  Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.

Authors:  Abhinandan Batra; Ravneet S Vohra; Steve M Chrzanowski; David W Hammers; Donovan J Lott; Krista Vandenborne; Glenn A Walter; Sean C Forbes
Journal:  J Appl Physiol (1985)       Date:  2019-04-04

3.  Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism.

Authors:  R Renjini; N Gayathri; A Nalini; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

4.  Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice.

Authors:  Dejia Li; Yongping Yue; Yi Lai; Chady H Hakim; Dongsheng Duan
Journal:  J Pathol       Date:  2010-10-28       Impact factor: 7.996

5.  Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy.

Authors:  Jessica A Chadwick; Sarah A Swager; Jeovanna Lowe; Steven S Welc; James G Tidball; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

6.  Peroxisome proliferator-activated receptor γ coactivator1- gene α transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle.

Authors:  Richard Godin; Frederic Daussin; Stefan Matecki; Tong Li; Basil J Petrof; Yan Burelle
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

7.  Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization.

Authors:  Joshua J Martindale; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2013-12-19       Impact factor: 5.000

8.  Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers.

Authors:  Vyacheslav M Shkryl; Adriano S Martins; Nina D Ullrich; Martha C Nowycky; Ernst Niggli; Natalia Shirokova
Journal:  Pflugers Arch       Date:  2009-04-22       Impact factor: 3.657

9.  Specific knockdown of delta-sarcoglycan gene in C2C12 in vitro causes post-translational loss of other sarcoglycans without mechanical stress.

Authors:  Michiyo Honda; Mari Hosoda; Nobuyuki Kanzawa; Takahide Tsuchiya; Teruhiko Toyo-oka
Journal:  Mol Cell Biochem       Date:  2008-12-16       Impact factor: 3.396

10.  Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.

Authors:  M Khairallah; R J Khairallah; M E Young; B G Allen; M A Gillis; G Danialou; C F Deschepper; B J Petrof; C Des Rosiers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.